Todos os tópicos
immunotherapy
0 menções esta semana
0
Social
0
Notícias
0
Blog
Science & Health
Moderna and Merck cancer vaccine cuts melanoma recurrence by 44% in late-stage trial
há 6d
Science & Health
mRNA vaccine shows early promise against pancreatic cancer in phase 1 trial
há 6d
Science & Health
Moderna and Merck vaccine cuts melanoma recurrence risk by 44% in phase 3 study
há 6d
Science & Health
mRNA melanoma vaccine cuts recurrence risk by 44% in interim Phase 3 data
há 6d